NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Short-term stability of the molecular forms of prostate-specific antigen and effect on percent complexed prostate-specific antigen and percent free prostate-specific antigen.

Author(s): Sokoll LJ, Bruzek DJ, Dua R, Dunn W, Mohr P, Wallerson G, Eisenberger M, Partin AW, Chan DW

Publication: Urology, 2002, Vol. 60, Page 24-30

PubMed ID: 12384159 PubMed Review Paper? No

Purpose of Paper

The purpose of this paper was to determine the effects of storage temperature and duration on total (t) prostate specific antigen (PSA), free PSA (fPSA), and complexed PSA (cPSA) in serum from healthy men and those with prostate cancer or elevated PSA in the absence of cancer using two analyzers.

Conclusion of Paper

tPSA, cPSA and fPSA were stable in serum stored for 1 week at -20 degrees C, but tPSA decreased significantly after storage of serum for 48 h at 4 degrees C or room temperature, cPSA declined significantly with more than 8 h of storage at room temperature or 24 h at 4 degrees C, and fPSA declined significantly after storage at room temperature for more than 48 h or at 4 degrees C for more than 24 h. The percent cPSA and fPSA relative tPSA were unaffected by storage at room temperature or -20 degrees C but were affected by storage at 4 degrees C.

Studies

  1. Study Purpose

    The purpose of this study was to determine the effects of storage temperature and duration on tPSA, fPSA, and cPSA in serum from healthy men and those with prostate cancer or elevated PSA in the absence of cancer using two analyzers. Blood was centrifuged within 2 h of collection, and serum was analyzed immediately or following experimental storage.

    Summary of Findings:

    tPSA, cPSA and fPSA were stable in serum stored for 1 week at -20 degrees C. tPSA decreased significantly between 48 h and 1 week of storage at 4 degrees C or room temperature using the Access analyzer (<10%) and using the Immuno I analyzer (<20%), but the changes were only clinically significant when storage was at room temperature. Similarly, cPSA declined significantly after more than 8 h of storage at room temperature or 24 h at 4 degrees C, but the cPSA to tPSA ratio was unaffected by storage at room temperature or -20 degrees C and increased insignificantly (10-15%) with storage at 4 degrees C for 1 week. fPSA declined significantly after storage at room temperature for more than 48 h (10% decline) or at 4 degrees C for more than 24 h (15% decline), but the percent fPSA of tPSA was unaffected by storage at room temperature and declined by 20% after 48 h of storage at 4 degrees C. fPSA levels were more variable than cPSA levels, and their variability increased with storage at 4 degrees C and room temperature.

    Biospecimens
    Preservative Types
    • None (Fresh)
    Diagnoses:
    • Normal
    • Neoplastic - Carcinoma
    Platform:
    AnalyteTechnology Platform
    Glycoprotein Clinical chemistry/auto analyzer
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Storage Storage duration 0 h
    4 h
    8 h
    24 h
    48 h
    1 week
    Storage Storage temperature -20 degrees C
    4 degrees C
    Room temperature
    Clinical chemistry/auto analyzer Specific Technology platform Beckman Coulter Access analyzer
    Bayer Immuno 1 analyzer

You Recently Viewed  

News and Announcements

  • April 24, 2024: Biobanking for Precision Medicine Seminar

  • Most Popular SOPs in March 2024

  • New SOPs Available

  • More...